智通财经APP获悉，百奥赛图-B(02315)尾盘涨超7%，截至发稿，涨7.06%，报61港元，成交额1.14亿港元。
消息面上，4月9日，四环医药与百奥赛图正式签署战略合作协定。双方将依托百奥赛图领先的全人抗体开发平台，结合四环医药在药物开发、生产和商业化方面的深厚经验，围绕减重等多个疾病领域的创新药物研发开展合作与交流。
东吴证券发布研报称，百奥赛图AI模型通过海量、独家的真实抗体分子数据训练，持续进行“新数据生产-验证-AI进化”，从而有能力筛选数十亿条全人源抗体序列，同时保障候选抗体药物序列的高特异性和可开发性，降低后续研发风险。AI自动化体系有望加速“千鼠万抗”潜力释放，打造高效率、规模化的研发生产体系。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.